Ipratropium bromide is an inhaled medication that relaxes the airways to make breathing easier. It belongs to a class of drugs called anticholinergics, and it’s primarily used as a maintenance treatment for chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It also comes in a nasal spray form to treat runny nose from colds or allergies. You may recognize it by the brand name Atrovent.
How Ipratropium Opens the Airways
Your airways are lined with smooth muscle that tightens or relaxes in response to chemical signals from your nervous system. One of those signals comes from a molecule called acetylcholine, which binds to receptors on airway muscle and tells it to contract. When those muscles contract, your airways narrow and breathing becomes harder.
Ipratropium works by blocking those receptors so acetylcholine can’t deliver its “squeeze” signal. With the signal blocked, the smooth muscle relaxes and the airways widen. The drug also reduces mucus production from glands in the airway lining, which helps keep the passages clearer. It blocks all five subtypes of the receptors involved (called muscarinic receptors), rather than targeting specific ones. This broad blocking action is what makes it effective but also explains some of its side effects, like dry mouth.
What It Treats
The inhaled form is FDA-approved for maintenance treatment of bronchospasm associated with COPD. That means it’s designed for daily, scheduled use to keep airways open over time, not as a rescue inhaler when you’re suddenly short of breath. It is also used off-label during asthma flare-ups, particularly in emergency settings where it’s given alongside a fast-acting bronchodilator.
The nasal spray version treats a different problem entirely: runny nose. A 0.06% concentration is approved for relieving rhinorrhea (the medical term for a persistently runny nose) caused by the common cold or seasonal allergies in adults and children age 5 and older. A weaker 0.03% version treats year-round runny nose from both allergic and nonallergic causes in adults and children age 6 and older. One important limitation: the nasal spray does not relieve congestion, sneezing, or postnasal drip.
How Quickly It Works
Ipratropium is classified as a short-acting anticholinergic, meaning each dose lasts about six to eight hours. That’s why it’s typically used three to four times a day. This distinguishes it from newer, long-acting alternatives like tiotropium, which lasts a full 24 hours and requires only one daily dose. For people who find multiple daily doses inconvenient, a long-acting option may be a better fit, but ipratropium remains widely used because of its established safety record and versatility.
Combination With Other Bronchodilators
Ipratropium is frequently paired with albuterol, a fast-acting bronchodilator that works through a completely different pathway. Albuterol stimulates receptors that actively relax airway muscle, while ipratropium blocks the signals that tighten it. These two mechanisms complement each other. Clinical trials have shown that the combination produces significantly greater improvement in airflow than albuterol alone, without increasing side effects. This combination is available as a single product (sold as Combivent or DuoNeb) and is commonly used in both COPD management and acute asthma treatment in emergency departments.
In pediatric emergency settings, ipratropium is almost always given alongside albuterol during moderate to severe asthma attacks rather than used on its own. The doses are weight-based: children under 20 kg typically receive a lower dose, while those 20 kg and above get a higher one.
How It’s Taken
Ipratropium comes in three forms for the inhaled version: a metered-dose inhaler (the standard handheld “puffer”), a soft mist inhaler, and a liquid solution used with a nebulizer. With the inhaler, a typical adult dose is two puffs four times a day. With the nebulizer, the standard adult dose is 500 micrograms three or four times daily, spaced every six to eight hours. Your prescriber will choose the delivery method based on your ability to coordinate the inhaler technique and the severity of your condition. Nebulizers are more common in hospital settings or for people who have difficulty using handheld inhalers.
For the nasal spray, you’ll typically spray it into each nostril two to three times daily, depending on which concentration you’re using and what you’re treating.
Common Side Effects
Because ipratropium blocks acetylcholine receptors throughout the body (not just in the lungs), it can cause drying effects in areas where those receptors are active. The most common side effect is dry mouth, which many people notice within the first few days of use. Other relatively frequent effects include headache, cough, and a bitter taste after inhaling. Nosebleeds and nasal dryness are common with the nasal spray.
Blurred vision can occur if the mist contacts your eyes, which is more likely with a nebulizer mask that doesn’t fit snugly. This happens because the drug can temporarily affect the muscles that control your pupil and lens. For the same reason, people with narrow-angle glaucoma need to be especially careful: accidental eye exposure could raise pressure inside the eye. People with an enlarged prostate should also be aware that anticholinergics can worsen urinary retention, since the same type of receptors help control bladder muscle function.
Who Should Use Caution
Ipratropium is generally well tolerated, but a few groups need extra vigilance. If you have narrow-angle glaucoma, make sure your inhaler technique directs the mist away from your eyes, and use a mouthpiece rather than a face mask for nebulizer treatments. If you have benign prostatic hyperplasia or any condition that makes urination difficult, the drug’s drying and muscle-relaxing effects could make that worse. People with a known allergy to atropine or similar compounds should avoid ipratropium, since it’s chemically related.
One thing ipratropium is not: a rescue medication. Its onset is slower than albuterol’s, so it won’t bail you out of a sudden breathing emergency on its own. If you’re relying on it during a COPD flare and not getting relief, that’s a sign you need a separate fast-acting rescue inhaler in your plan.